2025-2027

ST. JOHN’S UNIVERSITY

COLLEGE OF PHARMACY
AND HEALTH SCIENCES

PHARMACEUTICAL INDUSTRY
FELLOWSHIP PROGRAM

In partnership with
A MESSAGE FROM OUR
CHIEF MEDICAL OFFICER
“Dear Prospective Fellow,

On behalf of American Regent’s Medical Department (ARMD), we

would like to thank you for considering a fellowship with American
Regent. As a leading pharmaceutical company and injectable
manufacturer, we are committed to advancing patient health and
well-being through innovation and a strong focus on product
safety. Our Medical Affairs Fellowship is designed to cultivate the
next generation of pharmaceutical leaders by providing invaluable
experience and skills to drive progress in patient care. We are
excited about the opportunity to support your development and
help you make a significant impact in the healthcare industry.

We look forward to your application and the possibility of

welcoming you to our team.”

Ravi Tayi, MD, MPH

VP, Chief Medical Officer

CONTENTS
A Message from our Chief Medical Officer .................... 2

About American Regent, Inc ..…..................................... 3-4

Medical Affairs Fellowship Program ............................... 5

Elective Rotation Opportunities ...................................... 6

Program Leadership ......................................................... 7

Current Fellows ................................................................ 8

Fellowship Preceptors ...................................................... 9

Alumni Highlight ............................................................. 10

About St. John’s University .............................................. 11

How to Apply .................................................................... 12

2
ABOUT AMERICAN REGENT
About American Regent:

American Regent has a long history in the pharmaceutical community. Since the launch of our company under the name
American Quinine in 1967 to our recent product launches of Tralement (2020), Multrys (2021), and an expanded indication
for Injectafer for patients with heart failure (2023), American Regent keeps the health of patients as our guiding principle.

American Regent is a leading manufacturer of high quality generic and branded specialty injectables. We maintain a robust
and diversified pipeline for future growth encompassing multiple disease indications, along with a proven record of fast-
tracking both NDAs and ANDAs with innovative regulatory strategies. American Regent remains in an excellent position
for future growth because of our capabilities in the area of pharmaceutical product development. Our development
capabilities include hormones, controlled substances, cytotoxic molecules, imaging products, antibiotics, nutritional
products, and complex generics (peptides, microspheres, lipid based nano-carriers drug delivery systems).

The American Regent team is committed to providing the ever-changing healthcare marketplace with a growing and
diversified portfolio of branded and generic specialty injectable products for healthcare providers and their patients.

Reliability Speed Flexibility Quality

Between all three of our Developing excellence in American Regent, with its When it comes to quality,
US manufacturing sites, speed is a critical focus for US-based manufacturing our organization focuses
we have the capability American Regent, because and short delivery on prevention rather than
to manufacture over 70 we believe patients should timelines, has flexibility in remediation
million units annually never have to wait for the production scheduling—
medications they need ensuring rapid responses to
changes in market demand

Currently Supported Products

Tralement®
(trace elements injection 4*, USP)
*Each mL contains zinc 3 mg, copper 0.3 mg, manganese 55 mcg, and selenium 60 mcg.

Paclitaxel
Protein-Bound Particles
for Injectable Suspension
(Albumin-Bound)

Injectafer®, the Injectafer® logo, Venofer®, and the Venofer® logo are trademarks of Vifor (International), Inc., Switzerland.
Tralement® is a registered trademark of American Regent, Inc.
Multrys® is a registered trademark of American Regent, Inc.
Patents pending.

Learn more at: www.americanregent.com

3
 American Regent Timeline

A team of experts
founded American
Quinine to supply Tralement® (trace
high-quality elements
parenteral Venofer® (iron injection*, USP),
products to sucrose injection, the first
medical USP), now the #1 Injectafer® (ferric FDA-approved Selenious Acid
communities in selling IV iron in carboxymaltose trace elements Injection, USP is
the US and the US,* is injection)* is FDA injection is launched in a
Canada approved Approved introduced single-dose vial
1967 2000 2013 2020 2022

1996 2005 2016 2021 2023

American Regent Sankyo merges Launch of Multrys (trace
®
American Regent
Laboratories with Daiichi ProvayBlue® elements acquires and then
introduces Pharmaceutical (methylene blue) injection*, USP) is merges with HBT
Dexferrum® (iron Company, Ltd. Injection, 0.5%, launched Labs, Inc.
dextran injection, to become USP*
USP Daiichi-Sankyo
Company, Ltd.

American Regent Locations

Back to Contents 4
MEDICAL AFFAIRS
Pharmacists in the Medical Affairs Department provide efficient and unbiased medical information concerning the
company’s pharmaceutical products to healthcare professionals, consumers, and internal associates.
Currently recruiting one fellow for 2025-2027

1st Year Core Rotations

Publications / Scientific Promotional Material Medical Science Liaison

Medical Information
Communications Review (MSL)

Medical Affairs Overview:

• Develop and utilize strong clinical trial analysis skills to

evaluate medical literature, interpret scientific data, and
support healthcare professionals and consumers

• Create and present educational lectures on

products and disease states to internal and
external stakeholders

• Attend medical/scientific meetings to ensure an

in-depth understanding of the latest advances
and updated scientific information that will help
shape our publication and Investigator Sponsored
Study strategies

• Work with the Medical Affairs team including, but

not limited to: Medical Communications Leads,
Medical Science Liaisons, Medical Directors, Medical Writers, and other relevant team members on the development
and approval of core clinical material

• Manage company expectations while effectively integrating key clinical messages for dissemination to a wide array
of audiences

• Acquire the medical expertise and experience to thrive in the pharmaceutical industry while complying with FDA
and PhRMA regulations

Medical Science Liaison (MSL) Overview:

• Establish and maintain working relationships with healthcare professionals

• Provide education by creating scientific dialogue around American Regent

products and sponsored research

• Shadow the Medical Science Liaison (MSL) team and attend relevant
conferences to deepen their understanding of Medical Affairs in a
professional, pharmaceutical industry setting

*Fellows will be required to execute a confidentiality agreement with American Regent.

5
FELLOWSHIP ELECTIVE ROTATIONS
The second-year fellow will have the option to rotate through a variety of functional areas to foster professional
growth and to identify areas of interest.
Second Year Rotations:

Second Year
Electives

Clinical Research Safety/ Commercial &

Regulatory Affairs
and Development Pharmacovigilance Marketing

*Second-year elective rotations include, but are not limited to Clinical Research and Development, Regulatory Affairs, Safety/
Pharmacovigilance and Commercial & Marketing. Rotation availability is subject to change.

Clinical Research and Development:

• Learn the operational aspects of clinical trial designs from initiation, execution, and study completion

• Work with Clinical Operations to manage and update study time lines and budgets, and participate in the processes
of ongoing data review, analysis, and reporting while understanding the roles and responsibilities of clinical team
members

• Understand the lifecycle of clinical trials, identify study milestones, and develop study timelines that align with the
clinical development plan

• Utilize clinical research skills inclusive of systematic literature reviews, oral and written communication skills, and the
preparation of abstracts, articles in scientific journals, and study training materials for internal and external stakeholders

Regulatory Affairs:
• Gain an understanding of the regulations, guidelines, standard practices, and roles of Regulatory Strategy in the
development of products for commercialization

• Provide strategic input to support the development, filing, and regulatory approval of new drug products

• Participate in planning and preparing for interactions with Regulatory Health Authorities, and generate responses to
inquiries

• Contribute to drafting regulatory documents and participate in filing and maintaining Investigational New Drugs (INDs)
and New Drug Applications (NDAs)

Safety/Pharmacovigilance:
• Develop an understanding of pharmacovigilance processes within the Argus Safety Database

• Prepare and review aggregate reports under the supervision of the PV Department

• Participate in surveillance and signal detection for company products in a variety of different therapeutic areas

• Establish knowledge of MedDRA coding and applicable regulatory requirements

Commercial & Marketing:

• Provide input into commercial strategy, messaging, and tactical development

• Translate pertinent clinical study results into marketing and educational tools

• Train sales personnel on clinical subject matter

• Develop the required skills to synthesize information, generate insights, formulate solutions, and present findings to
internal and external stakeholders

Back to Contents 6
PROGRAM LEADERSHIP
“The American Regent Medical Affairs Fellowship represents an excellent opportunity for
a PharmD to gain pharmaceutical industry experience and expand their clinical knowledge
through active participation on the Medical Affairs team.

The fellowship provides an opportunity to obtain an understanding of the role of Medical

Affairs in the biopharmaceutical industry; develop clinical data analysis, interpretation, and
communication skills; gain the ability to recognize unmet patient needs and render clinical
insights; and develop industry-appropriate professional skills. The fellow will interact with
Medical Information, Medical Communications, Scientific Alliances, Medical Education,
Medical Director, and Medical Science Liaison teams, and with key cross-functional groups
including Safety, Regulatory, and Clinical Development.”

Syed Numan, MD, MBA, PMP

Senior Medical Director, Head of Medical Affairs

“The American Regent Medical Affairs Fellowship is geared for highly motivated
individuals seeking to enhance their careers and obtain pharmaceutical industry
experience. This two-year program provides a unique opportunity for fellows to develop
key skills in Medical Affairs while offering flexibility to explore additional functional areas
based on personal interest. The fellows become an integral part of the American Regent
team and will gain experience in understanding strategy implementation to support
scientific and commercial goals. This fellowship program will provide direct mentorship
to foster professional growth and development as well as essential experiences for a
successful career in the pharmaceutical industry.”

Kelly Mahoney, PharmD, RPh

Senior Manager, Medical Affairs
Fellowship Program Director, Medical Information Preceptor

“It is an honor and pleasure serving as Faculty Coordinator for this wonderful post-
doctoral fellowship opportunity offered through St. John’s University and American
Regent. Fellows completing this exceptional two-year program are highly marketable and
stand to secure cutting-edge positions within the pharmaceutical industry primarily due to
the mentorship, professional project opportunities, research experience, and exposure to
multiple cross-functional areas within American Regent.”

William M. Maidhof, PharmD

Associate Professor/Industry Professional
Fellowship Coordinator – St. John’s University and American Regent, Inc.

“For the past 15 years St. John’s University, College of Pharmacy and Health Sciences,
has partnered with American Regent to provide Doctor of Pharmacy graduates with
structured postgraduate education fellowships that develop leadership, practice, research,
and teaching skills to succeed in the industry today and in the future. The University is
proud of its longstanding affiliation with American Regent and the success of our past
and current fellows.”

Joseph M. Brocavich, PharmD

Associate Dean for Pharmacy Programs - St. John’s University

7
CURRENT FELLOWS
“The American Regent and St. John’s University fellowship program offers
the prospective fellow a unique opportunity to explore various elements
of Medical Affairs, as well as other areas of interest in different functional
areas that align with their professional goals. This robust fellowship program
within a mid-sized company is structured to be flexible to allow the fellow to
gain invaluable experience and create a meaningful impact in the business.
All of the mentors are always ready to lend a helping hand to help you reach
your goals for the most rewarding experience.

The academic component at St. John’s University allows the fellow to gain
research and teaching experience, as well as participate in graduate degree
programs. At St. John’s University, you will truly feel like you are part of
a family with amazing mentors that promote personal and professional
growth, networking, and expanding your knowledge and skills. This
program will set a foundation for a successful career in the pharmaceutical
industry.”

Christina Fridman, PharmD

Medical Affairs
Second-year Fellow
Temple University School of Pharmacy

“The American Regent and St. John’s University fellowship program enables
fellows to develop the essential skills needed to become competitive
professionals in the pharmaceutical industry. This fellowship is unique
because it allows fellows the freedom to choose areas of interest and make
specific goals. All mentors in the program are dedicated to providing the
best possible learning experiences. The program’s structure allows fellows to
gain an understanding of the various areas within Medical Affairs.

The partnership with St. John’s University enhances fellows’ professional

development by offering graduate degree classes, academic experience, and
research projects. At St. John’s University, you will receive the support of
all mentors, ensuring the best possible experiences and aiding your growth
both professionally and personally. This experience will equip prospective
fellows for a successful future in the pharmaceutical industry.”

Peter Attia, PharmD

Medical Affairs
First-year Fellow
Saint Joseph’s University, Philadelphia College of Pharmacy

The American Regent fellowship recruits yearly for Medical Affairs.

Fellowships are remote with professional development days located on the
St. John’s University campus in Queens, NY.

Currently Recruiting for Medical Affairs

2025-2027

Back to Contents 8
FELLOWSHIP PRECEPTORS

Hina Japes, PharmD Anisha Pirani, PharmD

Director, Medical Affairs Director, Medical Science Liaison
Scientific Communications

Emily Huynh, PharmD MaryAnn Rago, MBA, PharmD

Manager, Medical Affairs Senior Manager, Medical Affairs
Publications / Scientific Communications Promotional Material Review

Frances Gatto, B.S., RPh, PharmD

Medical Information Manager

9
ALUMNI HIGHLIGHT

Medical Affairs

Emily Huynh, PharmD Brittany Nghiem, PharmD

Manager, Medical Affairs, American Regent, 2022-present Manager, US Marketing, Oncology, Daiichi Sankyo,
Medical Affairs Fellow, 2020-22 2023-present
Medical Affairs Fellow, 2021-23
Jacob Beebe, PharmD, RPh
Manager, Medical Affairs, American Regent, 2024-present
Medical Affairs Fellow, 2022-24

Medical Affairs & Pharmaceutical Marketing

Arun Mathew, PharmD, MBA, MPS Andy He, PharmD, RPh

Senior Medical Director, BridgeBio Pharma, 2021-present Group Medical Director, US Medical Affairs, Lung Cancer,
Senior Medical Science Liaison, Ultragenyx, 2019-21 Johnson & Johnson, 2024- present
Medical Affairs & Pharmaceutical Marketing Fellow, 2017-19 Medical Director, US Medical Affairs, Oncology, Janssen,
2021-24
Jaclyn Viola, PharmD, RPh Associate Director, US Medical Affairs, Oncology, Daiichi
Marketing Director, US Vaccines, Pfizer, 2021-present Sankyo, 2018-21
Senior Manager, US Marketing, Rare Diseases, Pfizer, Senior Manager, Global Medical Affairs and Clinical
2019-21 Development, Bayer, 2015-18
Senior Manager, US Marketing, Oncology, Pfizer, 2018-19 Manager, Medical Affairs, American Regent, 2013-15
Product Manager, Marketing & Access Strategy, Iron Medical Affairs & Pharmaceutical Marketing Fellow, 2011-13
Franchise Marketing, Daiichi Sankyo, 2017-18
Product Manager, Iron Franchise Marketing, American Ryan Kuriakose, PharmD, MS
Regent, 2015-16 Marketing Lead, Marketing, Mednition, 2020-present
Medical Affairs & Pharmaceutical Marketing Fellow, 2013-15 Senior Manager, Marketing, Glooko, 2019-20
Vice President of Strategy and Business Development,
Jennifer Myers, PharmD, RPh Orphidia, 2016-19
Medical Science Liaison, Associate Director Immunology, Analytics Product Manager, Omnicell, 2013-16
Dermatology, Novartis, 2017-present Product Manager, Marketing, American Regent, 2012-13
Medical Science Liaison, AbbVie, 2015-17 Medical Affairs & Pharmaceutical Marketing Fellow, 2010-12
Associate Product Manager, Marketing, American Regent,
2014-15
Medical Affairs & Pharmaceutical Marketing Fellow, 2012-14

Clinical Research & Development

John Jeffrey Jones, PharmD, RPh Anna Krupa, PharmD, RPh, MS

Director, Clinical Scientist, RemeGen Biosciences, Clinical Scientist (AD), MorphoSys, 2023-Present
2024-present Global Senior Clinical Scientist, CSL Behring, 2019-2023
Scientific Director, Rare Disease, Amgen, 2023-24 Clinical Research & Development Fellow, 2017-19
Director, Clinical Scientist, Horizon, 2021-23
Associate Director, Clinical Development, Avrobio,
2020-21
Associate Director, Clinical Development, Stealth
BioTherapeutics, 2020
Senior Clinical Development Specialist, Stealth
BioTherapeutics, 2018-20
Clinical Research & Development Fellow, 2016-18

Back to Contents 10
St. John’s University College of Pharmacy and Health Fellows at St. John’s:
Sciences provides undergraduate, graduate, and post-
doctoral programs focused on global impact, which The fellow will be a full time St. John’s University
cultivates the tools necessary to find solutions to employee. A competitive stipend will be provided, as
complicated healthcare issues. Located in Queens, NY, St. well as options for comprehensive health, dental, and
John’s commitment to excellence and renowned faculty vision insurance.
inspire students to practice patient-centered care and
shape the future of healthcare. Each fellow is responsible for completing a semester-long
teaching requirement at the university and an additional
St. John’s University will empower diverse learners fellowship research project that may include original
with quality education for life. Through innovative research, or the development, enhancement, or evaluation
teaching, research, and service we will foster rational, of some aspect of operations or patient care services.
spirited inquiry and intelligent reflection. Our student
centered approach will be shaped by a caring, energized, Upon Fellowship Completion:
nimble culture. Enlivened by our distinctive mission, our
graduates will excel in the competencies and values
required for leadership and service in a rapidly evolving Certificate of Completion
global community. As a Catholic and Vincentian university, Teaching Certificate
we will be known worldwide for addressing issues of
poverty and social justice.
Additional Fellowship Opportunities:

• The fellow may apply for an affiliate faculty

appointment for St. John’s University College of
Pharmacy and Health Sciences

• Precept St. John’s University Doctor of Pharmacy

Candidates

• Perform collaborative research with

St. John’s faculty

• Enroll with tuition remittance for Graduate Degree

programs (Master’s or PhD degrees)

Learn more at: https://www.stjohns.edu

11
APPLY NOW
Eligibility:

Potential applicants for the St. John’s University/American Regent fellowship programs must meet the following criteria:

• Graduate from an Accreditation Council for Pharmacy Education (ACPE) accredited Doctor of Pharmacy Program

• Genuine interest in the pharmaceutical industry

• Eligible to work in the United States

How to Apply:

Please electronically send all required items and correspondence to:

stjfellowships@stjohns.edu

Required items: Deadlines:

Curriculum Vitae October 21, 2024

Letter of Intent October 21, 2024

College Transcript October 28, 2024

*does not have to include the fall semester grades

Three Letters of Recommendation October 28, 2024

Schedule an Interview:

Virtual interviews will be provided upon submission of a Letter of Intent and CV beginning early November.

Note: The American Regent fellowship recruits yearly for Medical Affairs. Fellowships are remote with professional
development days located on the St. John’s University campus in Queens, NY.

Questions:

Please contact stjfellowships@stjohns.edu for any and all questions regarding the fellowship program or
application process.

For more information, please visit:

https://www.stjohns.edu/resources/places/pharmaceutical-industry-fellowship-programs

Alliance of Industry Fellowship Associates Fellowship Offers

Recognizing that the choice of a Post-Doctoral Industry Fellowship is an important decision, AIFA exists to promote a
common aspect of each of our program’s cultures by supporting a consensus first offer date of December 16, 2024
for all Fellowship candidates.

We hope that other academic and non-academic Fellowship Programs will respect this timeline to allow for best
program fit for candidates.

Back to Contents 12
American Regent

5 Ramsey Rd
Shirley, NY 11967
www.americanregent.com

In partnership with

St. John’s University

8000 Utopia Parkway

Queens, NY 11439
www.stjohns.edu

©2024 American Regent, Inc.

NP-IN-US-0302

Back to Contents